Fine Wine correction provides favourable entry point for investors

A correction in some of the world’s leading Fine Wine vintages has provided a favourable entry point for investors, according to Moncharm Wine Traders.

The appeal of fine wine investment lies in its scarcity and ever-increasing demand. With supply levels failing to keep up with the surge in interest from affluent collectors, the prices of the world’s most sought-after wines have skyrocketed. In 2018, a single bottle of Domaine Romanee Conti – de la Romanee Conti 1945 fetched a staggering $558,000 at a Christie’s auction, setting a new record for the most expensive bottle of wine ever sold.

Since then, there has been a period of softness in leading vintages, which has taken some of the frothiness out of the market and created a possible entry point for long-term investors in the asset class.

The Liv-ex 1000, a broad measure of the fine wine market, is down 13.3% over the past year, but the longer-term trend remains intact. Within the broader index, there are leading component vintages, such as Mouton and Lafite Rothschild, that are changing hands at price well beneath previous highs.

Despite the rise of tech stocks and AI companies, Moncharm Wine Traders believes the so-called ‘passion investment’ remains a competitive investment option. The Liv-ex 1000 index has achieved annualised returns of 15.45% over the past twenty years.

According to Matthew Knight, head of private client sales at Moncharm Wine Traders, a London-based fine wine specialist, the recent cooling off period in 2023 has created an attractive buying opportunity for investors and collectors alike. “Investment-graded wines are offering a fantastic entry point for new collectors to establish their first holdings,” Knight said.

“After all, nobody wants to buy at the top of the market. For investors with medium-long term time horizons, being able to buy some of the best vintages of the likes of Mouton and Lafite Rothschild at their current levels is a very attractive proposition indeed.”

For more about Fine Wine Investing, please see this free guide.

FTSE 100 steams higher on interest rate optimism, JD Sports bounces back

London’s leading index started the week with a spring in its step, gaining over 1% at one point in early trade before falling back.

“The FTSE 100 made a strong start to June with resources, energy and financial stocks among those making solid gains,” said AJ Bell investment director Russ Mould.

The driving force behind Monday morning’s positive start was optimism around interest rates and a strong session in Asia overnight.

“Positive vibes are powering the FTSE 100 higher, as fresh hopes swirl that interest rate cuts are not as far off as feared,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

“Strong trading in Asia has laid the groundwork for an upbeat session, as investors take took cues from gains on Wall Street on Friday. Signs of weaker consumer spending patterns have lifted expectations that upwards price pressures could ease off and that the Fed may be less inclined to keep interest rates higher for longer.”

Economic data is set to dominate trade this week, with a raft of manufacturing data due to be released before the Non-Farm Payrolls on Friday.

Traders will also be looking forward to the European Central Bank’s interest rate decision this week and the possibility of a the first rate cut from a major western central bank after a two year hiking cycle.

Should the ECB cut rates, it will increase the chance of the Bank of England and Federal Reserve cutting rates in the near term. Although there is little indication central banks will make several rate cuts this year, simply cutting rates once will mark the end of the hiking cycle and boost consumer and investor sentiment. This may underpin further gains in the stocks.

JD Sports bounces back

JD Sports was the FTSE 100’s top riser on Monday, surging 7.4%, as it completely erased losses incurred on Friday after the release of its full-year results. The sports retailer said its Q1 sales were down compared to the same period last year but investors are choosing to look slower sales to the group’s future expansion across North America.

The FTSE 100’s gains were broad on Monday, with 87 of the constituents trading in positive territory at the time of writing.

St James’s Place’s recovery continued as shares gained another 4% after JP Morgan upgraded the stock to ‘overweight’.

GSK was the FTSE 100’s top faller following the news it was facing litigation in Delaware related to Zantac potentially causing cancer in patients. GSK shares were down 9% at the time of writing.

“Investors had reached a point of some comfort with GSK’s Zantac issue as a series of US lawsuits linking the heartburn drug to cancer appeared to be running out of steam,” Russ Mould said.

“However, a judge in Delaware has thrown a significant spanner into the works by giving the green light for 70,000 cases to go forward and by allowing expert witnesses to testify in court that the drug may cause cancer.

“GSK and the other parties involved, Pfizer and Sanofi, have made clear they disagree with the ruling and GSK has said it will mount an appeal.

“However, in the short term this just pours more uncertainty over the investment case. An uncomfortable comparison for GSK management can be drawn with AstraZeneca, which has left its counterpart for dust in recent times and is forging ahead with ambitious growth targets.”

AIM movers: Power Resources proposed uranium joint venture and CRISM Therapeutics shares continue to decline

1

Eleco (LON: ELCO) shares have risen 13% to 121.5p ahead of the construction and asset management software provider’s AGM on Tuesday. This is the highest level since 2021. The switch from software sales to a SaaS model is beginning to show through in improving profit momentum.

Power Metal Resources (LON: POW) has secured a £2m loan note investment from ACAM, which is also negotiating a uranium-focused joint venture, which would include all of Power Metal’s uranium licences. This would mean that the flotation of Uranium Energy Exploration will not happen – that has already cost £500,000 – and neither will previously proposed disposals. There would be a £10m investment in Power Metal Resources Canada so that ACAM would have a 70% stake. The loan notes bear interest of 10%/year and there will be 13.3 million warrants issued that are exercisable at 15p each. The share price increased 11.8% to 19p.

Deltic Energy (LON: DELT) has been granted an extension to 12 June to seek ways of funding its share of the costs of the North Sea Pensacola well, where it has a 30% working interest. This cost could be £15m. Deltic Energy would have to withdraw from the licence if not funding partner can be secured and discussions are ongoing. Canaccord Genuity has a NPV10 based target price of 110p, which includes 90p for the 25% working interest in the Selene target, where Deltic is fully funded for the well. The share price recovered 10.6% to 13p.

Mosman Oil & Gas (LON: MSMN) is paying $500,000 for a 10% interest in a US helium project in Las Animas County, Colorado. This is an area with known helium deposits. There are five helium prospects and a well will be drilled for each of them. The sale of oil and gas asset will help finance the move into helium. The share price improved 9.3% to 0.0235p.

FALLERS

Beacon Energy (LON: BCE) has not been able to produce a stabilised flow rate from the SCHB-2 sidetrack in the Erfelden field in Germany. Based on bottom hole pressures and flow rates obtained the initial response from the reservoir was poor. The well will be temporarily shut-in and data analysed. This well was expected to produce 9,000 barrel of oil equivalent/day. This cash would have funded further exploration and development. The share price slumped by four-fifths to 0.0115p.

CRISM Therapeutics Corporation (LON: CRTX) was formed when brain tumour treatment developer Extruded Pharmaceuticals reversed into Amur Minerals Corporation on Friday. The opening share price was 24p, but it ended the day at 11.5p and it has declined a further 21.7% to 9p. Some shareholders in the original mining company are probably not interested in healthcare and want to get out. This may hamper the share price in the short-term. CRISM has developed ChemoSeed, which is a treatment for glioblastoma and high-grade glioma, which are brain tumours where there is no current cure. It is an implantable, bioresorbable drug delivery platform.

Cameroon-focused oil and gas company Tower Resources (LON: TRP) reported a $450,000 loss for 2023. The rig to drill the NJOM-3 appraisal well on the Thali licence will not be delivered until the fourth quarter. This hole will cost $13.4m and the company is seeking a farm-in partner to cover some of that cost. The share price fell 19.4% to 0.0125p.

Bushveld Minerals (LON: BMN) has gained South African government approval for its sale of 64% of Mokopane, but it is still subject to due diligence and change of control for the mining and prospecting licence. Mokopane is a vanadium project. The share price slipped 14.2% to 0.7p.

Shein set for £51bn London IPO

Shein is reportedly preparing to fire the starting gun on its London IPO this week in what will be the highest profile flotation for months.

The fast fashion retail company is thought to be seeking a valuation of over £51bn as London triumphs over New York in attracting Singapore-based Shein.

“It’s rumoured that it could file paperwork for an IPO as soon as this week, which may value the company at more than £51 billion,” said Susannah Streeter, head of money and markets, Hargreaves Lansdown.

Streeter continued to explain that while Shein’s listing will be very welcomed with open arms by London’s struggling capital markets, there are ESG considerations which may prevent some investors taking a stake in the company.

“While New York still holds immense pulling power, and was the company’s first choice, plans for a listing there look unlikely given the lack of a welcome by regulators,” Streeter said.

“This is over its ties to China, where it was founded, and questions raised over its supply chain and working conditions. London looks set to be the second-choice destination and, while this would be a boost for the city, is likely to present deep ESG issues for investors to navigate.”

“Shein has come under significant criticism for the huge volumes of cheap clothes it produces, the lack of transparency in its supply chain and its appropriation of other designers’ work. Given these concerns, investors could be wary if ESG is on their priority list. Nonetheless confirmation of listing may be fresh election campaign fodder for the Conservatives, who are likely to say it demonstrates that government efforts in wooing firms to launch IPOs in London are paying off.”

S&P 500 weekly technical outlook 3rd June

Last week we felt that the index looked vulnerable to a pullback, some selling has materialised in the past few days largely as expected, however the selling was not enough yet to feel that the sentiment is over.

The Dow Jones in comparison has moved back to its recent lows, for the S&P 500 to post a comparable move it would need to slide down towards the 5,100 area highlighted by us in recent weeks.

The index has been in a broad bull run for the past year, wide blue channel. Within this broad channel price action had found some resistance from the parallel black line, which then became support on the minor weakness in April.

This support area continues to be the natural area for significant buying interest. So we are still concerned that the index could slip towards the 5100 area in the coming days before the buyers are confident enough to move back into the market in enough scale to turn the market. Also there are some signs that the “AI bubble” which had been powering the market is starting to cool

Leaving a cautious outlook again for the week ahead. On any move down towards the 5,100 area we would need a clear break lower to turn more outright negative, as for the moment it is more that the AI led buying of recent months has cooled and that some of the fizzle has left the market, rather than there being any serious signs yet that the powerful 12 month bull trend is under threat.

Beacon Energy shares crater after disappointing Schwarzbach update

Beacon Energy shares sank on Monday after the oil and gas exploration and production company with onshore assets in Germany released an update on its Schwarzbach 2(3.) sidetrack well in the Erfelden field.

The company has been unable to establish a stabilised flow rate from the reservoir, and the drill rig is being demobilised. Such was the extent of investor disdain for the update, Beacon Energy shares were down 78% at the time of writing.

The sidetrack well extended 85 meters from the original wellbore at a depth of 2,145 meters, placing it approximately 9 meters away from the original well in the Lower PBS formation.

After installing a production liner and electric submersible pump (ESP), the well began producing intermittently with frequent stalling issues preventing a stabilised flow rate.

Initial data suggests a poor reservoir response, with bottom-hole pressures and flow rates lower than expected. As a result, Beacon has temporarily shut-in the well to allow the drilling rig to demobilise. During this time, the company will obtain pressure build-up data to better analyse the reservoir performance.

“Having safely drilled the SCHB-2 sidetrack and installed the ESP, it is disappointing a sustained flow rate has not yet been achieved. Whilst pressure build up data, to be obtained in the coming days, will provide clarity, the initial response from the reservoir appears disappointing,” said Stewart MacDonald, Incoming CEO of the Beacon Energy.

“Following reconnection to the production facility, a long-term stabilised flow rate should be established. We remain convinced that Erfelden is a material and potentially highly valuable onshore oil discovery with Best Estimated recoverable reserves of 7.2mmbbl.  The Company will now consider its options to maximise the value of the resource we have discovered.”

AIM reversal: CRISM Therapeutics brain cancer treatment potential

Brain tumour treatment developer Extruded Pharmaceuticals reversed into Amur Minerals Corporation, which had sold its mining asset and become a shell, to form CRISM Therapeutics Corporation on 31 May. There was a one-for-160 share consolidation prior to the readmission.

The shell had cash in it, but it will not last long. Management believes that there is enough to start a phase II clinical trial for the ChemoSeed implantable, bioresorbable drug delivery platform.

The opening share price was 24p, but it ended the day at 11.5p after more than 145,000 shares were traded – mainly sells. Th...

Directors Deals: Warpaint London moving to new heights

Warpaint London (LSE: W7L) non-executive Sharon Daly acquired an initial 4,080 shares at 490p each. This is in contrast to sales by other directors.

The finance director Neil Rodol exercised 250,000 options at 122p each and sold the shares at 485p each. At the beginning of May chief executive Samuel Bazini and managing director Eoin Macleaod each sold 3.5 million shares. The each retain 15.95 million shares. Thir combind stake is 41.3% of the cosmetics supplier.

Business

AIM-quoted Warpaint London owns a number of affordable cosmetics brands, including W7 and Technic. There is also a...

Aquis weekly movers: Arbuthnot Banking special dividend

Chairman Geoffrey Miller has increased his shareholding in TruSpine Technologies (LON: TSP) from 7.24% to 9.03% after he acquired 2.5 million shares at 1.5p each from LCS. AIM-quoted Vela Technologies (LON: VELA) has cut its stake from 9.9% to 4.3%. The share price rose 26.7% to 2.85p.

Constantine Logothetis has increased his stake in SulNOx Group (LON: SNOX) to 24.1%. The share price increased 16.4% to 35.5p.

Arbuthnot Banking Group (LON: ARBB) has decided to pay a special dividend of 20p/share on top of its interim dividend of 20p/share, up from 19p/share in 2023. The two dividends will be paid at the same time on 20 June. The share price improved 4.01% to 972.5p.

FALLERS

Apollon Formularies (LON: APOL) shares slumped 70% to 0.0075p after shareholders voted in favour of leaving Aquis.  

Capital for Colleagues (LON: CFCP) reported an interim pre-tax profit of £985,000, up from £933,000. NAV was 87.32p/share at the end of February 2024. A 2p/share dividend has been subsequently paid. The share price fell 10.3% to 65p.

Valereum (LON: VLRM) chairman James Formolli has subscribed £2m for shares at 3.6p each. The share price declined 7.27% to 5.1p. Instead of warrants he will receive 15 million GATE tokens. Valereum has signed a strategic partnership with Securities Trading Technology Mauritius to improve Valereum’s core technology. The focus is Bridge Digital FMI, the company’s blockchain digital financial markets infrastructure.  

S-Ventures (LON: SVEN) has delayed the announcement of its figures for the 15 months to December 2023 because the audit will not be completed by the end of June. The share price slipped 2.44% to 2p.

Digital assets investor KR1 (LON: KR1) had net assets of 95.43p/share at the end of April 2024. Celestia accounts for 34.2% of the portfolio and Polkadot for 14.3%. There was £1.16m of income generated from digital assets during the month. The share price dipped 1.86% to 79p.

Marula Mining (LON: MARU) has signed an offtake agreement with Fujax UK for manganese ore production from the Larisoro mine in Kenya. The agreement covers an initial 2,000 tonnes of manganese ore with further minimum monthly deliveries of 5,000 tonnes, but nominal monthly sales of 20,000 tonnes/month for 12 months. Deliveries have started. Assay results from Larisoro show an average grade of 35.73% manganese. The share price is 1.37% lower at 9p.

AIM weekly movers: Trafalgar Property esport reversal plan

5

Trading in Trafalgar Property (LON: TRAF) shares was suspended after a 50% rise to 0.06p. The company has confirmed it is negotiating a reverse takeover of Ecap Esport. At the end of September 2023, Ecap Esport had net assets of £2.67m, including intangible assets of £3.94m, and its ultimate parent company was Esboz Ltd which sold the intangible assets to the company.

Cleaner fuels developer Quadrise (LON: QED) has signed an addendum to the Morocco representation agreement with Younes Maamar that was announced in March 2019. The original 13 million warrants issued have expired and 15.6 million warrants will be awarded conditional on achieving milestones. The initial tranche of 3.6 million warrants is exercisable at 1.452p each. The rest will be awarded after securing a refinery supply source and a commercial MSAR fuel supply agreement with OCP, which Quadrise has signed a commercial framework with concerning its processing plant. The share price jumped 49.7% to 2.205p.

Mongolian oil producer Petro Matad (LON: MATD) has received local government regulatory approvals to allow the 2024 operational programme to start. This will lead to the completion of the Heron-1 well for production. Approvals are still awaited from central government for certifying the Block XX exploitation area as state special purpose land. The share price increased 44.8% to 4.2p.

Golden Metal Resources (LON: GMET) is accelerating the development of the Pilot Mountain tungsten copper silver zinc project. A schedule and budget estimate are being evaluated to prepare for the preliminary feasibility study. The share price improved 35% to 21.6p.

FALLERS

Oil and gas producer Longboat Energy (LON: LBE) says net production at the Statfjord satellites has been disappointing this year. Two out of five redevelopment wells are still not producing. Average production was 401boe/day in the first four months of 2024 rising to 544boe/day so far in May. Further capital expenditure is required. Longboat Energy is reducing costs and additional funds will be required. A share issue is an option. The share price dived 60.3% to 7.25p.

Oil and gas company Corcel (LON: CRCL) says the operator has suspended drilling and well testing at KON-11 (18% net interest) in Angola. Initial results have not led to the reactivation of the Tobias field. The block partners are reviewing how to progress the development of the field. Management still believes the asset should be significant value. The share price slid 47.7% to 0.17p.

Online building materials retailer CMO Group (LON: CMO) reported a 14% drop in revenues to £71.5m with plumbing sales holding up better than other sectors. There was a swing from a pre-tax profit of £175,000 to a loss of £2.33m. Net debt was £600,000. The tiles market continues to decline, but there are signs of recovery in the overall market. Like-for-like sales orders were 18.2% lower, and the second quarter decline has slowed to 7.9%. The share price is 40.9% lower at 13p.

Premier African Minerals (LON: PREM) has paused mining at the Zulu lithium and tantalum project in Zimbabwe. This will enable the installation of an additional conditioning cell and it should be completed by 10 July. The share price fell 22.9% to 0.1176p.